Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06404658

Analgesic Efficacy of Genicular Nerve Block Versus (IPack Block ) in Patients Undergoing (ACL) Repair

Analgesic Efficacy of Genicular Nerve Block Versus Local Anaesthetic Infiltration Between Popliteal Artery and Capsule of the Knee (IPACK Block ) in Patients Undergoing Anterior Cruciate Ligament (ACL) Repair by Knee Arthroscopy . A Randomized Controlled Prospective Study .

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Beni-Suef University · Academic / Other
Sex
All
Age
15 Years – 45 Years
Healthy volunteers
Accepted

Summary

One of the most common injuries to the knee is an anterior cruciate ligament (ACL) sprain or tear due to trauma ACL damage is crippling and often requires repair with an arthroscopic method, which is an outpatient surgery. Nevertheless, patients experience severe postoperative pain on the first day after the ACL reconstruction.Efficient postsurgery pain management is an important part of patient recovery that is also crucial for their satisfaction.

Detailed description

The optimum role of peripheral nerve blocks in ACL reconstruction continue to be debated as a component of multi-modal analgesia . As such ,an ideal block for ACLR would target sensation but not motor function,have minimal complication risk,and be easily reproducible The genicular nerves include branches from the femoral, common peroneal, saphenous, tibial, and obturator nerves which innervate the knee capsule . The superolateral, superomedial, and inferomedial On the other hand, the interspace between the Popliteal Artery and Capsule of the Knee (IPACK) block provides analgesia on the posterior knee joint, and the application of a genicular or IPACK block has been be associated with promising outcomes following the ACLR surgery

Conditions

Interventions

TypeNameDescription
PROCEDUREGenicular nerve blockpatients who receive Genicular nerve block with spinal anathesia .

Timeline

Start date
2024-05-12
Primary completion
2024-10-30
Completion
2024-10-30
First posted
2024-05-08
Last updated
2024-05-14

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06404658. Inclusion in this directory is not an endorsement.